Maliwong, J.; Sahakitpichan, P.; Chimnoi, N.; Ruchirawat, S.; Kanchanapoom, T. Isoquinoline Alkaloids from the Tubers of Stephania pierrei. Phytochem. Lett. 2021, 43, 140-144.

01 Jun 2021
0
0

Maliwong, J.; Sahakitpichan, P.; Chimnoi, N.; Ruchirawat, S.; Kanchanapoom, T. Isoquinoline Alkaloids from the Tubers of Stephania pierrei. Phytochem. Lett. 2021, 43, 140-144.

Tags

Share this

Related Posts

The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Sriprapat S, Aeksowan S, Sapsutthipas S, Chotwiwatthanakun C, Suttijitpaisal P, Pratanaphon R, Khow O, Sitprija V, Ratanabanangkoon K Toxicon41p57-64(2003 Jan)
28 Jan 2003
0

The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Sriprapat S, Aeksowan S, Sapsutthipas S, Chotwiwatthanakun C, Suttijitpaisal P, Pratanaphon R, Khow O, Sitprija V, Ratanabanangkoon K Toxicon41p57-64(2003 Jan)

The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Sriprapat S, Aeksowan S, Sapsutthipas S, Chotwiwatthanakun C, Suttijitpaisal P, Pratanaphon R, Khow O, Sitprija V, Ratanabanangkoon K Toxicon41p57-64(2003 Jan)
View More
Juberg-Hayward syndrome and Roberts syndrome are allelic, caused by mutations in ESCO2. Kantaputra PN*, Dejkhamron P, Tongsima S, Ngamphiw C, Intachai W, Ngiwsara L, Sawangareetrakul P, Svasti J, Olsen B, Cairns JRK, Bumroongkit K. Arch Oral Biol. 2020 Nov;119:104918.
01 Nov 2020
0

Juberg-Hayward syndrome and Roberts syndrome are allelic, caused by mutations in ESCO2. Kantaputra PN*, Dejkhamron P, Tongsima S, Ngamphiw C, Intachai W, Ngiwsara L, Sawangareetrakul P, Svasti J, Olsen B, Cairns JRK, Bumroongkit K. Arch Oral Biol. 2020 Nov;119:104918.

  Juberg-Hayward syndrome and Roberts syndrome are allelic, caused by mutations in ESCO2. Kantaputra PN*, Dejkhamron P, Tongsima S, Ngamphiw C, Intachai W, Ngiwsara L, Sawangareetrakul P, Svasti J, Olsen B, Cairns JRK, Bumroongkit K. Arch Oral Biol. 2020 Nov;119:104918.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More